What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?

BACKGROUND: Previous studies have shown that intraoperative ultrasonography (IOUS) during hepatic resection for malignancy changes the operative plan or identifies occult unresectable disease in a large proportion of patients. This study was undertaken to reassess the yield of IOUS in light of recent improvements in preoperative staging. STUDY DESIGN: Patients with potentially resectable primary or metastatic hepatic malignancies subjected to exploration, bimanual palpation of the liver, and IOUS were evaluated prospectively. Intraoperative findings were recorded, and preoperative imaging studies were reanalyzed by radiologists blinded to the intraoperative findings. The extent of disease based on preoperative imaging was compared with the intraoperative findings. RESULTS: From October 1997 until November 1998, 111 patients were evaluated. At exploration, a total of 77 new findings or findings different than suggested on the imaging studies were identified in 61 patients (55%), the most common of which was additional hepatic tumors (n = 37). Thirty-five of 77 (45%) new findings were identified by IOUS alone and 10 (13%) by palpation alone; the remainder were identified by both palpation and IOUS. Forty-seven of 61 patients (77%) underwent a complete resection despite new intraoperative findings, with a modification (n = 28) or no change (n = 19) in the planned operation. Twenty-one patients (19%) had new findings identified only on IOUS. Thirteen of these patients underwent resection with no change in the operative plan, six underwent a modified resection and two were considered to have unresectable disease based solely on the findings of IOUS. CONCLUSIONS: In patients with hepatic malignancies submitted to a potentially curative resection, new intraoperative findings or findings different than suggested on preoperative imaging studies are common. But resection with no change in the operative plan or a modified resection is still possible in the majority of patients despite such findings. The findings on IOUS alone rarely lead to a change in the operative plan.

Vertebral vein migration of a long-term central venous access catheter: a cause of brachial plexopathy.

We report a patient whose central venous catheter tip had migrated into the vertebral vein. Infusion of chemotherapy agents for cancer through this catheter resulted in brachial plexopathy.

Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy.

Diagnostic imaging plays an essential role in management of hepatobiliary tumors. High resolution images provided by computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound (US) allow detection of tumor within the liver. CT arterial portography remains the standard for detection of small lesions in the range of 1.5 cm, but noninvasive techniques such as contrast-enhanced helical CT and MR hold promise for comparable lesion detection. MRI provides lesion characterization for differentiation of benign and malignant tumors. Lesion characterization has been further improved by faster CT and MR techniques that allow imaging in both arterial and portal venous phases for characterization of lesions based on the rate and pattern of enhancement. Functional imaging such as 2-fluoro-2-deoxy-D-glucose-positron-emission tomography (FDG-PET) is increasingly utilized for detection of intrahepatic tumor and extrahepatic disease. Accuracy of FDG-PET for extrahepatic disease is better than conventional imaging and has been shown to change management in a significant number of patients. Imaging is also invaluable for surgical planning. Segmental anatomy is well shown by CT, MRI, and US. CT or MR angiography with newer 3D techniques delineate vascular variants and areas of encasement or occlusion by tumor. Biliary involvement at the hilus may be shown by US and MR cholangiography. Imaging detection of vascular involvement, bile duct extension, and lobar atrophy may alter the surgical approach.

Pancreatic signal intensity on T1-weighted fat saturation MR images: clinical correlation.

To determine whether signal intensity (SI) of the pancreas that was less than that of liver on T1-weighted fat-suppressed (T1FS) magnetic resonance (MR) images could be used to help predict the presence of pancreatic disease, three blinded independent observers graded pancreatic SI relative to liver and/or renal cortex in 89 patients on T1FS images. Results were correlated with patient age and diagnosis. Among the 47 patients with a clinically normal pancreas, pancreatic SI was higher than that of liver in 42 and equal to that of liver in the rest, none of whom had evidence of fatty pancreas. These five patients had a mean age of 71 years, compared with 55 years for patients whose pancreas was more intense than liver (P = .02). Of the 42 patients with a clinically abnormal pancreas, only eight had pancreatic SI higher than that of liver. The positive predictive value for normal pancreas of an SI higher than that of liver was 84% and the positive predictive value for abnormal pancreas of an SI less than or equal to that of liver was 88%, with an overall accuracy of 86%. If normal pancreatic SI is defined as higher than that of liver for patients younger than 60 years and as equal to or higher than that of liver for patients older than 60 years, the positive predictive value of normal SI becomes 76%, the positive predictive value of decreased SI becomes 100%, and the overall accuracy becomes 83%.(ABSTRACT TRUNCATED AT 250 WORDS)

Delineation of pancreas with MR imaging: multiobserver comparison of five pulse sequences.

The authors compared five magnetic resonance (MR) imaging pulse sequences for their ability to depict the pancreas in 59 patients, each evaluated with at least two of the five sequences. Focal pancreatic carcinomas were present in eight patients. The five sequences were T1-weighted spin echo (T1-SE), fat-suppressed T1-SE (T1-FS), T1-weighted gradient echo (T1-GRE), T2-weighted SE (T2-SE), and T2-weighted fast spin echo (T2-FSE). Using repeated-measures analysis, three blinded observers independently reviewed 198 separate MR imaging series and rated them on a 5-point scale with regard to image quality and depiction of pancreatic borders and the number of sections containing pancreatic and common bile ducts. The most superior and most inferior sections containing pancreas were recorded for each sequence in each patient. The results were compared with analysis of variance, and interobserver agreement was measured with the intraclass correlation coefficient (ICC). For image quality, all sequences were rated good to excellent, with the T1-SE sequence having the highest rating. For clarity of pancreatic borders, however, the T1-FS sequence was rated significantly higher (P < .006) than the other sequences; the T2-SE sequence was least satisfactory. Common bile and pancreatic ducts were seen in the most sections with the T2-FSE sequence. There were no significant differences regarding identification of the most superior and inferior sections containing pancreas, and the ICC was high (.91-.97) for all sequences. For detecting focal carcinomas, no single pulse sequence was sufficient.

Recurrent gallbladder carcinoma along laparoscopic cholecystectomy port tracks: CT demonstration.

PURPOSE: To describe the computed tomographic (CT) appearance of recurrent gallbladder carcinoma along port tracks after laparoscopic cholecystectomy and to assess the effect of recurrence on patient care. MATERIALS AND METHODS: Seventeen abdominal CT scans in 16 of 19 consecutive patients who underwent hepatic resection for gallbladder carcinoma diagnosed at laparoscopic cholecystectomy were reviewed retrospectively. Medical records were reviewed to determine the clinical effect of tumor recurrence along a port track. RESULTS: CT revealed 12 tumor recurrences along laparoscopic port tracks in six (32%) patients (mean, two recurrences per patient; range, one to four per patient). Eight (67%) CT-depicted recurrences appeared homogeneous, and nine (75%) directly involved subjacent omental fat. The mass was the only site of recurrence at CT in two (33%) patients. The presence of an abdominal wall tumor recurrence affected patient care in four (67%) of six patients. Histopathologic examination results confirmed recurrent tumor in all five (100%) patients who underwent biopsy. CONCLUSION: Tumor recurrence along port tracks is a potential complication of laparoscopic cholecystectomy when gallbladder carcinoma is present, even after subsequent hepatic resection is performed for attempted cure. Recurrences appear as a new or enlarging abdominal wall mass, often involving subjacent omental fat, and may be the only site of recurrent disease at CT. Demonstration of abdominal wall tumor recurrence affects patient care.

Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers.

PURPOSE: To compare the magnetic resonance (MR) imaging findings of primary hepatocellular carcinoma (HCC) in cirrhotic versus noncirrhotic livers. MATERIALS AND METHODS: MR images in 36 patients with HCC (30 men and she women aged 42-84 years [mean age, 65 years]) were retrospectively reviewed. The number and size of hepatic lesions were assessed. Lesion margins were categorized as well circumscribed or ill defined. The presence of a capsule, intratumoral high signal intensity on T1-weighted MR images, and a stellate scar were determined. RESULTS: Eleven (31%) patients had MR imaging evidence of cirrhosis, and 25 (69%) did not: Lesions in cirrhotic livers differed significantly from those in noncirrhotic livers in terms of size (22 cm2 vs 99 cm2, P < .05), frequency of a solitary lesion (27% vs 72%, P < .05), and frequency of a central scar (6% vs 50%, P < .05). There was no difference between the cirrhotic and noncirrhotic livers with regard to tumor margin, intratumoral high signal intensity on T1-weighted images, or tumor capsule. CONCLUSION: Differences exist in the MR imaging appearance of HCC between patients with and those without cirrhosis, although there is overlap of imaging findings.

Breast cancer: assessing the use of routine pelvic CT in patient evaluation.

OBJECTIVE: The purpose of this study was to determine the benefit of routine pelvic CT in the evaluation of patients with primary breast cancer and to assess the frequency with which equivocal or abnormal findings on pelvic CT prompted the performance of additional studies or procedures that yielded results relevant to patient care. MATERIALS AND METHODS: The reports of 6628 body CT scans that included images of at least the pelvis in 2426 patients with breast cancer during a 9-year period were reviewed. The presence and sites of reported definite or probable metastases or pelvic tumors were recorded for each scan. Also, the types and results of diagnostic examinations and procedures prompted by equivocal or abnormal findings on pelvic CT were recorded. RESULTS: Pelvic metastases shown on CT were the only known site of metastasis in 13 (0.5%) of 2426 patients, and four other patients (0.2%) had new or enlarging pelvic metastases despite the presence of stable extrapelvic metastases. The pelvic metastases in these 17 patients were located in bone only in 11 patients, in adnexa only in five patients, and in adnexa, endometrium, and bone in one patient. In addition, pelvic CT led to the performance of 204 additional radiologic examinations, including 186 pelvic sonographic examinations, and 50 surgical procedures; 215 (84.6%) of these 254 additional examinations and procedures yielded normal, benign, or indeterminate results. CONCLUSION: The routine use of pelvic CT in the evaluation of patients with breast cancer has an extremely low yield and often prompts performance of pelvic sonographic or surgical procedures, the results of which were rarely relevant to cancer therapy.

Incidental pulmonary emboli detected at helical CT: effect on patient care.

PURPOSE: To evaluate incidental pulmonary emboli detected at helical computed tomography (CT) and the effect on patient care. MATERIALS AND METHODS: A computer search of reports from 1,879 consecutive contrast material-enhanced helical CT scans identified 28 cases in which pulmonary emboli were suggested. These 28 scans were rereviewed by three radiologists to confirm intraluminal defects. Six cases were excluded (three because of tumor invasion, two arterial stump thrombi after pneumonectomy, one artifact). In four cases, pulmonary emboli were clinically suspected or diagnosed prior to CT. Pulmonary embolus was not suspected at CT in the remaining 18 patients who constituted the study group. The medical records were reviewed for predisposing factors, suspicion of pulmonary embolism, adjuvant studies, and resultant therapy. RESULTS: All 18 patients in the study group had predisposition for thromboembolic disease. Seven of these patients underwent confirmatory or correlative studies (angiography, radionuclide studies, or autopsy), and four patients had supportive studies documenting deep venous thrombosis. Eleven patients received anticoagulants or caval filter placement as a result of CT findings. CONCLUSION: Incidental pulmonary emboli were detected in approximately 1% of patients who underwent contrast-enhanced CT of the chest. All of these patients were at high risk for emboli. Therapeutic intervention was undertaken in 61% of these patients. While ultimate patient outcome is uncertain, the incidental CT diagnosis of pulmonary emboli appears accurate and affects patient care.

Metastatic lobular carcinoma of the breast: patterns of spread in the chest, abdomen, and pelvis on CT.

OBJECTIVE: We determined the pattern of spread of metastatic lobular carcinoma in the chest, abdomen, and pelvis on CT. MATERIALS AND METHODS: We identified 57 women (age range, 30-79 years; mean age, 57 years) with metastatic lobular carcinoma of the breast who underwent CT of the chest, abdomen, or pelvis between 1995 and 1998. Then two experienced oncology radiologists retrospectively reviewed 78 CT examinations of those patients to identify sites of metastatic disease and to identify complications caused by metastases. RESULTS: Metastases were identified in bone in 46 patients (81%), lymph nodes in 27 patients (47%), lung in 19 patients (33%), liver in 18 patients (32%), peritoneum in 17 patients (30%), colon in 15 patients (26%), pleura in 13 patients (23%), adnexa in 12 patients (21%), stomach in nine patients (16%), retroperitoneum in nine patients (16%), and small bowel in six patients (11%). Eighteen patients (32%) had gastrointestinal tract involvement that manifested as bowel wall thickening. Hydronephrosis was present in six patients (11%). CONCLUSION: Although lobular carcinoma metastasized to common metastatic sites of infiltrating ductal carcinoma, lobular carcinoma frequently metastasized to unusual sites, including the gastrointestinal tract, peritoneum, and adnexa. Gastrointestinal tract involvement was as frequent as liver involvement, appearing as bowel wall thickening on CT. Hydronephrosis was a complication of metastatic lobular carcinoma.